Anna U. Loengard - 13 Aug 2025 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: Director
Signature: /s/Peter J. Rivas as attorney-in-fact for Anna U. Loengard
Issuer symbol: CLOV
Transactions as of: 13 Aug 2025
Net transactions value: +$68,755
Form type: 4
Filing time: 14 Aug 2025, 16:44:26 UTC
Previous filing: 08 Jan 2025
Next filing: 08 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Loengard Anna U	Director	C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON	/s/Peter J. Rivas as attorney-in-fact for Anna U. Loengard	14 Aug 2025	0001952723

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Purchase	$31,200	+12,000	+77%	$2.60	27,600	13 Aug 2025	By Son IRA	F1
transaction	CLOV	Class A Common Stock	Purchase	$37,555	+14,500	+96%	$2.59	29,610	13 Aug 2025	By Daughter IRA	F2
holding	CLOV	Class A Common Stock						448,091	13 Aug 2025	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Held in a custodial IRA for the benefit of Reporting Person's son, for which the Reporting Person serves as custodian.
F2	Held in a custodial IRA for the benefit of Reporting Person's daughter, for which the Reporting Person serves as custodian.
F3	The Reporting Person no longer has a reportable beneficial interest in 151,725 shares held by her now ex-spouse. Such shares were included in the Reporting Person's prior ownership report.